GCG and diabetes mellitus: A recent study demonstrated that varying expression levels of SIRT1 in diabetes may be partly attributed to OS [20]; this is consistent with early-stage diabetic rats showing decreased SIRT1 expression, with expression levels returning to normal after treatment with the antioxidant glucagon-like peptide 1 analog exendin-4 (EX4) [23].